Age-related comorbidities and mortality in people living with HIV in rural Tanzania: data from a prospective cohort study (Publications)
ranged from 25.5% in the youngest to 29.1% in the oldest age group and contributed to mortality/LTFU [hazard ratios 2.24 (95% CI 1.65-3.04); P < 0.001]. Prevalence of tuberculosis was 21.4% [hazard ratios [...] comorbidities, assessed by means of International Classification of Diseases and Related Health problems 10th revision codes and clinical variables, derived from data collected from the Kilombero & Ulanga a [...] 31-46)], 11% were at least 50 years. During a median follow-up of 22.1...
Age-related comorbidities and mortality in people living with HIV in rural Tanzania: data from a prospective cohort study (Publications)
ranged from 25.5% in the youngest to 29.1% in the oldest age group and contributed to mortality/LTFU [hazard ratios 2.24 (95% CI 1.65-3.04); P < 0.001]. Prevalence of tuberculosis was 21.4% [hazard ratios [...] comorbidities, assessed by means of International Classification of Diseases and Related Health problems 10th revision codes and clinical variables, derived from data collected from the Kilombero & Ulanga a [...] 31-46)], 11% were at least 50 years. During a median follow-up of 22.1...
Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries (Publications)
illness history. The mean (SD) age and body mass index were 39.8 years old (13.2) and 25.9 kg/m(2) (4.7). Among them, 75 reported a total of 129 AE (27 serious), 46 being suspected to be related to APQ [...] 21 were due to cardiotoxicity (7.1%), mostly QT prolongation, while 6 were due to neurotoxicity (2.0%), mostly dizziness. Using QTcF correction, QT prolongation was observed in 17/143 participants (11 [...] few subjects were in this group. No new safety signal was reported. The overall...
Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries (Publications)
illness history. The mean (SD) age and body mass index were 39.8 years old (13.2) and 25.9 kg/m(2) (4.7). Among them, 75 reported a total of 129 AE (27 serious), 46 being suspected to be related to APQ [...] 21 were due to cardiotoxicity (7.1%), mostly QT prolongation, while 6 were due to neurotoxicity (2.0%), mostly dizziness. Using QTcF correction, QT prolongation was observed in 17/143 participants (11 [...] few subjects were in this group. No new safety signal was reported. The overall...
Maxine Whittaker, James Cook University, Australia 10:10 Climate Change and Health in Sub-Saharan Africa, Andrea Rother, University of Cape Town, South Africa 4b Prediction and Monitoring for Impact 09:30 Prediction [...] Swiss TPH 10:10 Surveillance of the Asian Tiger Mosquito in Switzerland, Pie Müller, Swiss TPH Session TS5 | Frameworks for Health System Resilience and Disaster Risk Reduction 5a Frameworks 11:10 Sendai [...] Janine Kuriger, Swiss Agency for Development and Cooperation,...
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled,... (Publications)
concentrations decreased by day 180 to 25.5 mug/mL (95% CI 20.6-31.5) in the high-dose group, 22.1 mug/mL (19.3-28.6) in the low-dose group, and 3.2 mug/mL (2.4-4.9) in the placebo group. 28 (57%) participants [...] (85%) were non-deployed, to receive high-dose vaccine (n=49), low-dose vaccine (n=51), or placebo (n=20). Participants were followed up for 6 months. No vaccine-related serious adverse events were reported [...] participants in the high-dose group, 33 (79%) of 42 participants in the...
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled,... (Publications)
concentrations decreased by day 180 to 25.5 mug/mL (95% CI 20.6-31.5) in the high-dose group, 22.1 mug/mL (19.3-28.6) in the low-dose group, and 3.2 mug/mL (2.4-4.9) in the placebo group. 28 (57%) participants [...] (85%) were non-deployed, to receive high-dose vaccine (n=49), low-dose vaccine (n=51), or placebo (n=20). Participants were followed up for 6 months. No vaccine-related serious adverse events were reported [...] participants in the high-dose group, 33 (79%) of 42 participants in the...
United Nations Population Fund, Switzerland 10:00 Room Change (15 minutes) Parallel Session 1-A: Innovations in Access to Maternal Health P1-A: Seminar Room 4 / 10:15-11:15 / Moderator: Leah Bohle, Swiss TPH [...] Women and Gender in Global Health 20 November 2024 Kreuzstrasse 2, 4123 Allschwil, Switzerland Women's health has evolved from a matter of equity to a critical scientific focus to advance global health [...] Gender Differences Menstrual Health Equity Programme Welcome and Plenary 08:45...
Investigation of antiplasmodial effects of terpenoid compounds isolated from myrrh (Publications)
nolide (4: ), 2-methoxyisogermafurenolide (5: ), 8-epi-2-methoxyisogermafurenolide (6: ), furanodienone (7: ), 1(10)Z,4Z-furanodien-6-one (8: ), rel-2R-methyl-5S-acetoxy-4R-furanogermacr-1(10)Z-en-6-one [...] (9: ), (1(10)E)-2-methoxy-8,12-epoxygermacra-1(10),7,11-trien-6-one (10: ), 2R-methoxyfuranodiene (11: ), 2-acetyloxyglechomanolide (12: ), 8-epi-2-acetyloxyglechomanolide (13: ), (1R,2R,4S)-1,2-epox [...] mansumbinol epoxide (20: ), mansumbinone (21: ), mansumbin-13(17)-en-3,16-dione (22:...
Investigation of antiplasmodial effects of terpenoid compounds isolated from myrrh (Publications)
nolide (4: ), 2-methoxyisogermafurenolide (5: ), 8-epi-2-methoxyisogermafurenolide (6: ), furanodienone (7: ), 1(10)Z,4Z-furanodien-6-one (8: ), rel-2R-methyl-5S-acetoxy-4R-furanogermacr-1(10)Z-en-6-one [...] (9: ), (1(10)E)-2-methoxy-8,12-epoxygermacra-1(10),7,11-trien-6-one (10: ), 2R-methoxyfuranodiene (11: ), 2-acetyloxyglechomanolide (12: ), 8-epi-2-acetyloxyglechomanolide (13: ), (1R,2R,4S)-1,2-epox [...] mansumbinol epoxide (20: ), mansumbinone (21: ), mansumbin-13(17)-en-3,16-dione (22:...
